streaming service, which considers DivX's patents invalid. Now the dispute moves to the UPC. In September, the German Federal Court of Justice dismissed DivX’s appeal against the Federal Patent Court’s
Chinese access control leader Hongmen Advanced Technology Corporation is now involved in a new patent dispute with its industry rival Shenzhen Jieshun Science and Technology Industry Co., Ltd.
infringes a patent held by Fresenius Kabi, thus overturning a first-instance decision. Fresenius Kabi alleges that Biogen’s Imraldi has infringed its EP 3 145 488 B1 for a ‘liquid pharmaceutical
Chinese cloud-computing giant Inspur has withdrawn its patent invalidity challenges against Hewlett Packard Enterprise (HPE), signaling a potential shift in the ongoing cross-border intellectual
Brazil has kept up its efforts to improve the protection and enforcement of IPR over the reporting period. The Brazilian IPR Office (INPI) continues reducing the patent and trade mark backlogs. INPI
The dental equipment industry is seeing increasingly fierce patent disputes. Several manufacturers are facing off in court. Now, the Higher Regional Court in Düsseldorf has dismissed a lawsuit filed
ToolGen’s EP 4 357 457 patent covering CRISPR-Cas9 RNP technology. EP 457 is a divisional patent of EP 4 397 759. Vertex, for whom Lonza manufactures the drug, had apparently anticipated this move.
amend their case and refile the claims, which the company then did. Battleground Munich Days before the Californian court published its decision, SAP launched a patent infringement action at the UPC
BioNTech yesterday announced its intention to acquire CureVac. The transaction could also end the global patent disputes between the two biotech companies in Germany, the UK, and the US. In a press
components for the printing plates. As the patents are also valid in the UK, the Japanese patent holder FujiFilm requested the court order the German subsidiaries of the US competitor to refrain from making